Sort
10,766 grants matching “checkpoint inhibitor”
Immune checkpoint inhibitors and accelerated coronary atherosclerosis
$1,041,129Tomas G Neilan · Massachusetts General Hospital · R01 · FY2022 · HL
Towards targeting the lymphoma microenvironment
$1,040,760Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2022 · CA
Molecular Pathogenesis of Neoplasia
$1,040,298John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
Identification of genetic interactors of Brca2
$1,039,510Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Metabolic basis of B cell lineage leukemia relapse
$1,036,898Markus Mãschen · Beckman Research Institute/City Of Hope · R35 · FY2017 · CA
Metabolic basis of B cell lineage leukemia relapse
$1,035,561Markus Mãschen · Beckman Research Institute/City Of Hope · R35 · FY2018 · CA
Metabolic basis of B cell lineage leukemia relapse
$1,035,016Markus Mãschen · Beckman Research Institute/City Of Hope · R35 · FY2020 · CA
Center for Lupus Research
$1,033,649Maria Virginia Pascual · Baylor Research Institute · P50 · FY2010 · AR
Initiation Of DNA Replication In Mammalian Chromosomes
$1,032,536Melvin Depamphilis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
Gene Expression At The Beginning Of Mammalian Development
$1,032,535Melvin Depamphilis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
Proteogenomic Predictors of Recurrence in Non-small Cell Lung Cancer
$1,032,286Ramaswamy Govindan · Washington University · U01 · FY2023 · CA
SBIR: In vivo engineering of B7-H3.CAR-T cells for ovarian cancer therapy
$1,031,566Ming Yang · Mucommune, Llc · R44 · FY2025 · CA
Tumor Microenvironment in Cancer Progression
$1,030,688Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Liver Cancer Program
$1,030,084Anuradha Budhu · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Identification of genetic interactors of Brca2
$1,029,736Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
$1,028,782Thomas M Roberts · Dana-Farber Cancer Inst · R35 · FY2022 · CA
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
$1,028,782Thomas M Roberts · Dana-Farber Cancer Inst · R35 · FY2023 · CA
Immunological Analysis of Brain Cancer
$1,025,686Masaki Terabe · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Immune checkpoint inhibitors and accelerated coronary atherosclerosis
$1,023,526Tomas G Neilan · Massachusetts General Hospital · R01 · FY2025 · HL
Molecular Pathogenesis of Neoplasia
$1,022,497Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis
$1,021,694Don W. Cleveland · University Of California, San Diego · R35 · FY2025 · GM
Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis
$1,021,694Don W. Cleveland · University Of California, San Diego · R35 · FY2023 · GM
Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis
$1,021,694Don W. Cleveland · University Of California, San Diego · R35 · FY2024 · GM
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,021,151Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Conserved Element DNA Vaccine
$1,021,081Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA